Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 28.35-21.6327.368.439.27

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is 28.35 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202528.35
Mar2024-21.63
Mar202327.36
Mar20228.43
Mar20219.27

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 28.35
Positive
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43
-9.06
Mar2021 9.27 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,942.3 Cr -1.2% 4.2% 22% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,348.0 Cr 0.7% -0.7% -11% Stock Analytics
DIVIS LABORATORIES ₹158,840.0 Cr NA -1.6% 12.1% Stock Analytics
CIPLA ₹124,222.0 Cr -2% -4% -5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,346.0 Cr 3.1% -0.9% 9.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,437.0 Cr -0.2% 2.4% 0% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.2%

4.2%

22%

SENSEX

-1.2%

0.5%

-1.8%


You may also like the below Video Courses